Mazorra Z.
330
Coauthors
23
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Inmunología | 23 |
| Cáncer | 19 |
| Medicina interna | 1 |
| Medicamento | 1 |
| Bioquímica | 1 |
| Infección | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 22 |
| Farmacología y terapéutica | 13 |
| Medicina y salud | 3 |
| Microorganismos, hongos y algas | 2 |
| Ginecología, obstetricia, pediatría, geriatría | 2 |
| Fisiología humana | 2 |
| Grupos de personas | 1 |
| Bioquímica | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 23 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Tania Crombet | 22 |
| Saavedra Hernández D. | 11 |
| Luaces P.L.o. | 10 |
| Lage Davila A. | 10 |
| Carmen Elena Viada | 8 |
| García Verdecia B. | 7 |
| Neninger Vinageras E. | 7 |
| González A. | 6 |
| Cepeda M. | 5 |
| Gonzalez Z. | 5 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck
ReviewAbstract: EGFR activation induces cell proliferation, neoformation of blood vessels, survival, and metastasisPalabras claves:eGFR, head and neck, Monoclonal antibody, nimotuzumab, RadiotherapyAutores:Iznaga-Escobar N., Mazorra Z., Mestre Fernández B., Tania CrombetFuentes:scopusCIMAvax-EGF: Toward long-term survival of advanced NSCLC
ReviewAbstract: Lung cancer remains one of the leading causes of cancer-related deaths. Non–small cell lung cancer (Palabras claves:cancer vaccine, CIMAvax-EGF, Clinical trial, EGF, Epidermal growth factor receptor, immunotherapy, non–small cell lung cancerAutores:Camilo Rodríguez, Carmen Elena Viada, Lage Davila A., Mazorra Z., Neninger Vinageras E., Saavedra Hernández D., Tania CrombetFuentes:scopusNimotuzumab: beyond the EGFR signaling cascade inhibition
ReviewAbstract: One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It activatesPalabras claves:antibody-dependent cell mediated cytotoxicity (ADCC), eGFR, HLA class I molecules, monoclonal antibodies, Natural killer cells, T cellsAutores:Chao L., Iznaga N., Lavastida A., Mazorra Z., Ramos M., Sanchez B., Tania CrombetFuentes:scopusImmunosenescence and gender: A study in healthy Cubans
ArticleAbstract: Background: The progressive decline in the immune function during ageing is termed immunosenescence.Palabras claves:Autores:de Jesús Badía Alvarez T., García Verdecia B., Lage Davila A., Leonard Rupalé I., Luaces P.L.o., Mazorra Z., Saavedra Hernández D., Tania CrombetFuentes:scopusImmunological evaluation of rheumatoid arthritis patients treated with itolizumab
ArticleAbstract: Rheumatoid arthritis is an autoimmune disease characterized by joint inflammation that affects approPalabras claves:Anti-idiotypic antibody response, Itolizumab, Peripheral lymphocytic counts, Proinflammatory cytokines, Rheumatoid ArthritisAutores:Aira L.E., Carmen Elena Viada, Chico A., Fuentes K.P., Gómez J.A., Gonzalez Z., Hernández P., Mazorra Z., Prada D.M.Fuentes:scopus